 | • レポートコード：MRC2-11QY02505 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗消化性潰瘍薬のグローバル市場について調査・分析したレポートです。種類別（プロトンポンプ阻害剤（PPI）、カリウム競合酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬）市場規模、用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗消化性潰瘍薬の競争状況、市場シェア ・世界の抗消化性潰瘍薬市場：種類別市場規模 2015年-2020年（プロトンポンプ阻害剤（PPI）、カリウム競合酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬） ・世界の抗消化性潰瘍薬市場：種類別市場規模予測 2021年-2026年（プロトンポンプ阻害剤（PPI）、カリウム競合酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬） ・世界の抗消化性潰瘍薬市場：用途別市場規模 2015年-2020年（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・世界の抗消化性潰瘍薬市場：用途別市場規模予測 2021年-2026年（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・北米の抗消化性潰瘍薬市場分析：米国、カナダ ・ヨーロッパの抗消化性潰瘍薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗消化性潰瘍薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗消化性潰瘍薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗消化性潰瘍薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eisai、Daewoong Pharmaceutical、Takeda Pharmaceutical、HeliCure、AstraZeneca、Ore Pharmaceuticals、Sihuan Pharmaceutical、GlaxoSmithKline、Pfizer、Abbott Laboratories、Yuhan Corporation、Cadila Healthcare、Boehringer Ingelheim ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Anti Peptic Ulcer Drugs Market
The global Anti Peptic Ulcer Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anti Peptic Ulcer Drugs Scope and Market Size
Anti Peptic Ulcer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti Peptic Ulcer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti Peptic Ulcer Drugs market is segmented into
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs
Segment by Application, the Anti Peptic Ulcer Drugs market is segmented into
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Regional and Country-level Analysis
The Anti Peptic Ulcer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti Peptic Ulcer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti Peptic Ulcer Drugs Market Share Analysis
Anti Peptic Ulcer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti Peptic Ulcer Drugs business, the date to enter into the Anti Peptic Ulcer Drugs market, Anti Peptic Ulcer Drugs product introduction, recent developments, etc.
The major vendors covered:
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Pharmaceuticals
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim
1 Study Coverage
1.1 Anti Peptic Ulcer Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti Peptic Ulcer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti Peptic Ulcer Drugs Market Size Growth Rate by Type
1.4.2 Proton Pump Inhibitors (PPIs)
1.4.3 Potassium-Competitive Acid Blockers (P-CAB)
1.4.4 Antacids
1.4.5 H2 Antagonists
1.4.6 Antibiotics
1.4.7 Ulcer Protective Drugs
1.5 Market by Application
1.5.1 Global Anti Peptic Ulcer Drugs Market Size Growth Rate by Application
1.5.2 Gastritis
1.5.3 Gastric Ulcers
1.5.4 Duodenal Ulcers
1.5.5 Gastroesophageal Reflux Disease (GERD)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti Peptic Ulcer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti Peptic Ulcer Drugs Revenue 2015-2026
2.1.2 Global Anti Peptic Ulcer Drugs Sales 2015-2026
2.2 Global Anti Peptic Ulcer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti Peptic Ulcer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti Peptic Ulcer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti Peptic Ulcer Drugs Competitor Landscape by Players
3.1 Anti Peptic Ulcer Drugs Sales by Manufacturers
3.1.1 Anti Peptic Ulcer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Anti Peptic Ulcer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Anti Peptic Ulcer Drugs Revenue by Manufacturers
3.2.1 Anti Peptic Ulcer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Anti Peptic Ulcer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti Peptic Ulcer Drugs Revenue in 2019
3.2.5 Global Anti Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti Peptic Ulcer Drugs Price by Manufacturers
3.4 Anti Peptic Ulcer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti Peptic Ulcer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti Peptic Ulcer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti Peptic Ulcer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti Peptic Ulcer Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti Peptic Ulcer Drugs Sales by Type (2015-2020)
4.1.2 Global Anti Peptic Ulcer Drugs Revenue by Type (2015-2020)
4.1.3 Anti Peptic Ulcer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti Peptic Ulcer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti Peptic Ulcer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti Peptic Ulcer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti Peptic Ulcer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti Peptic Ulcer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti Peptic Ulcer Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti Peptic Ulcer Drugs Sales by Application (2015-2020)
5.1.2 Global Anti Peptic Ulcer Drugs Revenue by Application (2015-2020)
5.1.3 Anti Peptic Ulcer Drugs Price by Application (2015-2020)
5.2 Anti Peptic Ulcer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti Peptic Ulcer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti Peptic Ulcer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti Peptic Ulcer Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti Peptic Ulcer Drugs by Country
6.1.1 North America Anti Peptic Ulcer Drugs Sales by Country
6.1.2 North America Anti Peptic Ulcer Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti Peptic Ulcer Drugs Market Facts & Figures by Type
6.3 North America Anti Peptic Ulcer Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Anti Peptic Ulcer Drugs by Country
7.1.1 Europe Anti Peptic Ulcer Drugs Sales by Country
7.1.2 Europe Anti Peptic Ulcer Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti Peptic Ulcer Drugs Market Facts & Figures by Type
7.3 Europe Anti Peptic Ulcer Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti Peptic Ulcer Drugs by Region
8.1.1 Asia Pacific Anti Peptic Ulcer Drugs Sales by Region
8.1.2 Asia Pacific Anti Peptic Ulcer Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti Peptic Ulcer Drugs Market Facts & Figures by Type
8.3 Asia Pacific Anti Peptic Ulcer Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti Peptic Ulcer Drugs by Country
9.1.1 Latin America Anti Peptic Ulcer Drugs Sales by Country
9.1.2 Latin America Anti Peptic Ulcer Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti Peptic Ulcer Drugs Market Facts & Figures by Type
9.3 Central & South America Anti Peptic Ulcer Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti Peptic Ulcer Drugs by Country
10.1.1 Middle East and Africa Anti Peptic Ulcer Drugs Sales by Country
10.1.2 Middle East and Africa Anti Peptic Ulcer Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti Peptic Ulcer Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Anti Peptic Ulcer Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Eisai
11.1.1 Eisai Corporation Information
11.1.2 Eisai Description and Business Overview
11.1.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Anti Peptic Ulcer Drugs Products Offered
11.1.5 Eisai Related Developments
11.2 Daewoong Pharmaceutical
11.2.1 Daewoong Pharmaceutical Corporation Information
11.2.2 Daewoong Pharmaceutical Description and Business Overview
11.2.3 Daewoong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Products Offered
11.2.5 Daewoong Pharmaceutical Related Developments
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Corporation Information
11.3.2 Takeda Pharmaceutical Description and Business Overview
11.3.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Products Offered
11.3.5 Takeda Pharmaceutical Related Developments
11.4 HeliCure
11.4.1 HeliCure Corporation Information
11.4.2 HeliCure Description and Business Overview
11.4.3 HeliCure Sales, Revenue and Gross Margin (2015-2020)
11.4.4 HeliCure Anti Peptic Ulcer Drugs Products Offered
11.4.5 HeliCure Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Anti Peptic Ulcer Drugs Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Ore Pharmaceuticals
11.6.1 Ore Pharmaceuticals Corporation Information
11.6.2 Ore Pharmaceuticals Description and Business Overview
11.6.3 Ore Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ore Pharmaceuticals Anti Peptic Ulcer Drugs Products Offered
11.6.5 Ore Pharmaceuticals Related Developments
11.7 Sihuan Pharmaceutical
11.7.1 Sihuan Pharmaceutical Corporation Information
11.7.2 Sihuan Pharmaceutical Description and Business Overview
11.7.3 Sihuan Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Products Offered
11.7.5 Sihuan Pharmaceutical Related Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description and Business Overview
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline Anti Peptic Ulcer Drugs Products Offered
11.8.5 GlaxoSmithKline Related Developments
11.9 Pfizer
11.9.1 Pfizer Corporation Information
11.9.2 Pfizer Description and Business Overview
11.9.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pfizer Anti Peptic Ulcer Drugs Products Offered
11.9.5 Pfizer Related Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Corporation Information
11.10.2 Abbott Laboratories Description and Business Overview
11.10.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Abbott Laboratories Anti Peptic Ulcer Drugs Products Offered
11.10.5 Abbott Laboratories Related Developments
11.1 Eisai
11.1.1 Eisai Corporation Information
11.1.2 Eisai Description and Business Overview
11.1.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Anti Peptic Ulcer Drugs Products Offered
11.1.5 Eisai Related Developments
11.12 Cadila Healthcare
11.12.1 Cadila Healthcare Corporation Information
11.12.2 Cadila Healthcare Description and Business Overview
11.12.3 Cadila Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Cadila Healthcare Products Offered
11.12.5 Cadila Healthcare Related Developments
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Corporation Information
11.13.2 Boehringer Ingelheim Description and Business Overview
11.13.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Boehringer Ingelheim Products Offered
11.13.5 Boehringer Ingelheim Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti Peptic Ulcer Drugs Market Estimates and Projections by Region
12.1.1 Global Anti Peptic Ulcer Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Anti Peptic Ulcer Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Anti Peptic Ulcer Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
12.2.2 North America: Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Anti Peptic Ulcer Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Anti Peptic Ulcer Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Anti Peptic Ulcer Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti Peptic Ulcer Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti Peptic Ulcer Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti Peptic Ulcer Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti Peptic Ulcer Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti Peptic Ulcer Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti Peptic Ulcer Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti Peptic Ulcer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti Peptic Ulcer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti Peptic Ulcer Drugs Market Segments
Table 2. Ranking of Global Top Anti Peptic Ulcer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti Peptic Ulcer Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Proton Pump Inhibitors (PPIs)
Table 5. Major Manufacturers of Potassium-Competitive Acid Blockers (P-CAB)
Table 6. Major Manufacturers of Antacids
Table 7. Major Manufacturers of H2 Antagonists
Table 8. Major Manufacturers of Antibiotics
Table 9. Major Manufacturers of Ulcer Protective Drugs
Table 10. Global Anti Peptic Ulcer Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Anti Peptic Ulcer Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Anti Peptic Ulcer Drugs Sales by Regions 2015-2020 (K Units)
Table 13. Global Anti Peptic Ulcer Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Anti Peptic Ulcer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Anti Peptic Ulcer Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Anti Peptic Ulcer Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Anti Peptic Ulcer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Anti Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Peptic Ulcer Drugs as of 2019)
Table 19. Anti Peptic Ulcer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Anti Peptic Ulcer Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Anti Peptic Ulcer Drugs Price (2015-2020) (USD/Pcs)
Table 22. Anti Peptic Ulcer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Anti Peptic Ulcer Drugs Product Type
Table 24. Date of International Manufacturers Enter into Anti Peptic Ulcer Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti Peptic Ulcer Drugs Sales by Type (2015-2020) (K Units)
Table 27. Global Anti Peptic Ulcer Drugs Sales Share by Type (2015-2020)
Table 28. Global Anti Peptic Ulcer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Anti Peptic Ulcer Drugs Revenue Share by Type (2015-2020)
Table 30. Anti Peptic Ulcer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Anti Peptic Ulcer Drugs Sales by Application (2015-2020) (K Units)
Table 32. Global Anti Peptic Ulcer Drugs Sales Share by Application (2015-2020)
Table 33. North America Anti Peptic Ulcer Drugs Sales by Country (2015-2020) (K Units)
Table 34. North America Anti Peptic Ulcer Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Anti Peptic Ulcer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Anti Peptic Ulcer Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Anti Peptic Ulcer Drugs Sales by Type (2015-2020) (K Units)
Table 38. North America Anti Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Anti Peptic Ulcer Drugs Sales by Application (2015-2020) (K Units)
Table 40. North America Anti Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Anti Peptic Ulcer Drugs Sales by Country (2015-2020) (K Units)
Table 42. Europe Anti Peptic Ulcer Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Anti Peptic Ulcer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Anti Peptic Ulcer Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Anti Peptic Ulcer Drugs Sales by Type (2015-2020) (K Units)
Table 46. Europe Anti Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Anti Peptic Ulcer Drugs Sales by Application (2015-2020) (K Units)
Table 48. Europe Anti Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Anti Peptic Ulcer Drugs Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Anti Peptic Ulcer Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Anti Peptic Ulcer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Anti Peptic Ulcer Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Anti Peptic Ulcer Drugs Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Anti Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Anti Peptic Ulcer Drugs Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Anti Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Anti Peptic Ulcer Drugs Sales by Country (2015-2020) (K Units)
Table 58. Latin America Anti Peptic Ulcer Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Anti Peptic Ulcer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Anti Peptic Ulcer Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Anti Peptic Ulcer Drugs Sales by Type (2015-2020) (K Units)
Table 62. Latin America Anti Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Anti Peptic Ulcer Drugs Sales by Application (2015-2020) (K Units)
Table 64. Latin America Anti Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Anti Peptic Ulcer Drugs Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Anti Peptic Ulcer Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Anti Peptic Ulcer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Anti Peptic Ulcer Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Anti Peptic Ulcer Drugs Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Anti Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Anti Peptic Ulcer Drugs Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Anti Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 73. Eisai Corporation Information
Table 74. Eisai Description and Major Businesses
Table 75. Eisai Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Eisai Product
Table 77. Eisai Recent Development
Table 78. Daewoong Pharmaceutical Corporation Information
Table 79. Daewoong Pharmaceutical Description and Major Businesses
Table 80. Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Daewoong Pharmaceutical Product
Table 82. Daewoong Pharmaceutical Recent Development
Table 83. Takeda Pharmaceutical Corporation Information
Table 84. Takeda Pharmaceutical Description and Major Businesses
Table 85. Takeda Pharmaceutical Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Takeda Pharmaceutical Product
Table 87. Takeda Pharmaceutical Recent Development
Table 88. HeliCure Corporation Information
Table 89. HeliCure Description and Major Businesses
Table 90. HeliCure Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. HeliCure Product
Table 92. HeliCure Recent Development
Table 93. AstraZeneca Corporation Information
Table 94. AstraZeneca Description and Major Businesses
Table 95. AstraZeneca Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. AstraZeneca Product
Table 97. AstraZeneca Recent Development
Table 98. Ore Pharmaceuticals Corporation Information
Table 99. Ore Pharmaceuticals Description and Major Businesses
Table 100. Ore Pharmaceuticals Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Ore Pharmaceuticals Product
Table 102. Ore Pharmaceuticals Recent Development
Table 103. Sihuan Pharmaceutical Corporation Information
Table 104. Sihuan Pharmaceutical Description and Major Businesses
Table 105. Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Sihuan Pharmaceutical Product
Table 107. Sihuan Pharmaceutical Recent Development
Table 108. GlaxoSmithKline Corporation Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. GlaxoSmithKline Product
Table 112. GlaxoSmithKline Recent Development
Table 113. Pfizer Corporation Information
Table 114. Pfizer Description and Major Businesses
Table 115. Pfizer Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Pfizer Product
Table 117. Pfizer Recent Development
Table 118. Abbott Laboratories Corporation Information
Table 119. Abbott Laboratories Description and Major Businesses
Table 120. Abbott Laboratories Anti Peptic Ulcer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Abbott Laboratories Product
Table 122. Abbott Laboratories Recent Development
Table 123. Yuhan Corporation Corporation Information
Table 124. Yuhan Corporation Description and Major Businesses
Table 125. Yuhan Corporation Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Yuhan Corporation Product
Table 127. Yuhan Corporation Recent Development
Table 128. Cadila Healthcare Corporation Information
Table 129. Cadila Healthcare Description and Major Businesses
Table 130. Cadila Healthcare Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Cadila Healthcare Product
Table 132. Cadila Healthcare Recent Development
Table 133. Boehringer Ingelheim Corporation Information
Table 134. Boehringer Ingelheim Description and Major Businesses
Table 135. Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Boehringer Ingelheim Product
Table 137. Boehringer Ingelheim Recent Development
Table 138. Global Anti Peptic Ulcer Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 139. Global Anti Peptic Ulcer Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 140. Global Anti Peptic Ulcer Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 141. Global Anti Peptic Ulcer Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 142. North America: Anti Peptic Ulcer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 143. North America: Anti Peptic Ulcer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Europe: Anti Peptic Ulcer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 145. Europe: Anti Peptic Ulcer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Asia Pacific: Anti Peptic Ulcer Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 147. Asia Pacific: Anti Peptic Ulcer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 148. Latin America: Anti Peptic Ulcer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 149. Latin America: Anti Peptic Ulcer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Middle East and Africa: Anti Peptic Ulcer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 151. Middle East and Africa: Anti Peptic Ulcer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 153. Key Challenges
Table 154. Market Risks
Table 155. Main Points Interviewed from Key Anti Peptic Ulcer Drugs Players
Table 156. Anti Peptic Ulcer Drugs Customers List
Table 157. Anti Peptic Ulcer Drugs Distributors List
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti Peptic Ulcer Drugs Product Picture
Figure 2. Global Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Proton Pump Inhibitors (PPIs) Product Picture
Figure 4. Potassium-Competitive Acid Blockers (P-CAB) Product Picture
Figure 5. Antacids Product Picture
Figure 6. H2 Antagonists Product Picture
Figure 7. Antibiotics Product Picture
Figure 8. Ulcer Protective Drugs Product Picture
Figure 9. Global Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Gastritis
Figure 11. Gastric Ulcers
Figure 12. Duodenal Ulcers
Figure 13. Gastroesophageal Reflux Disease (GERD)
Figure 14. Anti Peptic Ulcer Drugs Report Years Considered
Figure 15. Global Anti Peptic Ulcer Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Anti Peptic Ulcer Drugs Sales 2015-2026 (K Units)
Figure 17. Global Anti Peptic Ulcer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Anti Peptic Ulcer Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Anti Peptic Ulcer Drugs Sales Market Share by Region in 2019
Figure 20. Global Anti Peptic Ulcer Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Anti Peptic Ulcer Drugs Revenue Market Share by Region in 2019
Figure 22. Global Anti Peptic Ulcer Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Anti Peptic Ulcer Drugs Revenue in 2019
Figure 24. Anti Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Anti Peptic Ulcer Drugs Sales Market Share by Type in 2019
Figure 27. Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Anti Peptic Ulcer Drugs Revenue Market Share by Type in 2019
Figure 29. Global Anti Peptic Ulcer Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Anti Peptic Ulcer Drugs Sales Market Share by Application in 2019
Figure 32. Global Anti Peptic Ulcer Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Anti Peptic Ulcer Drugs Revenue Market Share by Application in 2019
Figure 34. North America Anti Peptic Ulcer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Anti Peptic Ulcer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Anti Peptic Ulcer Drugs Sales Market Share by Country in 2019
Figure 37. North America Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Anti Peptic Ulcer Drugs Market Share by Type in 2019
Figure 43. North America Anti Peptic Ulcer Drugs Market Share by Application in 2019
Figure 44. Europe Anti Peptic Ulcer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Anti Peptic Ulcer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Anti Peptic Ulcer Drugs Sales Market Share by Country in 2019
Figure 47. Europe Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Anti Peptic Ulcer Drugs Market Share by Type in 2019
Figure 59. Europe Anti Peptic Ulcer Drugs Market Share by Application in 2019
Figure 60. Asia Pacific Anti Peptic Ulcer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Anti Peptic Ulcer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Anti Peptic Ulcer Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Anti Peptic Ulcer Drugs Revenue Market Share by Region in 2019
Figure 64. China Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Anti Peptic Ulcer Drugs Market Share by Type in 2019
Figure 87. Asia Pacific Anti Peptic Ulcer Drugs Market Share by Application in 2019
Figure 88. Latin America Anti Peptic Ulcer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Anti Peptic Ulcer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Anti Peptic Ulcer Drugs Sales Market Share by Country in 2019
Figure 91. Latin America Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2019
Figure 92. Mexico Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Anti Peptic Ulcer Drugs Market Share by Type in 2019
Figure 99. Latin America Anti Peptic Ulcer Drugs Market Share by Application in 2019
Figure 100. Middle East and Africa Anti Peptic Ulcer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Anti Peptic Ulcer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Anti Peptic Ulcer Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Anti Peptic Ulcer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Anti Peptic Ulcer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Anti Peptic Ulcer Drugs Market Share by Type in 2019
Figure 111. Middle East and Africa Anti Peptic Ulcer Drugs Market Share by Application in 2019
Figure 112. North America Anti Peptic Ulcer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Anti Peptic Ulcer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Anti Peptic Ulcer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Anti Peptic Ulcer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Anti Peptic Ulcer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Anti Peptic Ulcer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Anti Peptic Ulcer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Anti Peptic Ulcer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Anti Peptic Ulcer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Anti Peptic Ulcer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
十二指腸潰瘍治療の世界市場（～2026年） Duodenal ulcer is a sore occurring in the upper area of the small intestine, the duodenum. Globally demand for duodenal ulcer treatment is expected to witness growth due to increasing prevalence of the disease. Market Analysis and Insights: Global Duodenal Ulcer Treatment Market The global Duodenal …- 糖尿病性足潰瘍治療薬の世界市場（～2026年） Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing br…
- 口内潰瘍治療の世界市場（～2026年） Mouth ulcers, also known as canker sores, are normally small, painful lesions that develop in mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers aren’t contagious and usually go away within one to two weeks. Most ulcers will heal completely without …
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…